In mice models, agnostic anti-GITR and anti-OX40 were shown to reduce tumor burden, deplete intra-tumoral Tregs, and increase the infiltration and function of effector T-cells [150,151,152,153]. The gene discussed is TNFRSF18; the disease is neoplasm.